C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 413/12 (2006.01) A61K 31/44 (2006.01) A61K 31/445 (2006.01) A61K 31/495 (2006.01) A61K 31/55 (2006.01) C07D 263/20 (2006.01) C07D 401/12 (2006.01) C07D 403/06 (2006.01) C07D 403/12 (2006.01) C07D 413/06 (2006.01) C07D 417/06 (2006.01) C07D 417/12 (2006.01) C07D 491/10 (2006.01) C07D 491/107 (2006.01)
Patent
CA 2122571
Novel compounds of the formula I (see formula I) in which R1, X and Y have the meanings given in Patent Claim 1, and their salts, inhibit the binding of fibrinogen to the fibrinogen receptor and can be used for treating thromboses, stroke, cardiac infarction, inflam- mations, arteriosclerosis, osteoporosis and tumours.
Bernotat-Danielowski Sabine
Gante Joachim
Juraszyk Horst
Melzer Guido
Prucher Helmut
Fetherstonhaugh & Co.
Merck Patent Gesellschaft Mit Beschraenkter Haftung
LandOfFree
Adhesion receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Adhesion receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Adhesion receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1953687